Literature DB >> 25661088

Genetic determinants of risk and progression in multiple sclerosis.

Alessandro Didonna1, Jorge R Oksenberg2.   

Abstract

Multiple sclerosis (MS) is an autoimmune disease that represents a primary cause of neurological disability in the young adult population. Converging evidence supports the importance of genetic determinants for MS etiology. However, with the exception of the major histocompatibility complex, their nature has been elusive for more than 20 years. In the last decade, the advent of large genome-wide association studies has significantly improved our understanding of the disease, leading to the golden era of MS genetic research. To date more than 110 genetic variants have been firmly associated to an increased risk of developing MS. A large part of these variants tag genes involved in the regulation of immune response and several of them are shared with other autoimmune diseases, suggesting a common etiological root for this class of disorders. Despite the impressive body of data obtained in the last years, we are still far from fully decoding MS genetic complexity. For example, we ignore how these genetic factors interact with each other and with the environment. Thus, the biggest challenge for the next era of MS research will consist in identifying and characterizing the molecular mechanisms and the cellular pathways in which these risk variants play a role.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Complex disease; GWAS; Multiple sclerosis; Risk variant

Mesh:

Year:  2015        PMID: 25661088      PMCID: PMC4524789          DOI: 10.1016/j.cca.2015.01.034

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  99 in total

1.  Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis.

Authors:  Serena Sanna; Maristella Pitzalis; Magdalena Zoledziewska; Ilenia Zara; Carlo Sidore; Raffaele Murru; Michael B Whalen; Fabio Busonero; Andrea Maschio; Gianna Costa; Maria Cristina Melis; Francesca Deidda; Fausto Poddie; Laura Morelli; Gabriele Farina; Yun Li; Mariano Dei; Sandra Lai; Antonella Mulas; Gianmauro Cuccuru; Eleonora Porcu; Liming Liang; Patrizia Zavattari; Loredana Moi; Elisa Deriu; M Francesca Urru; Michele Bajorek; Maria Anna Satta; Eleonora Cocco; Paola Ferrigno; Stefano Sotgiu; Maura Pugliatti; Sebastiano Traccis; Andrea Angius; Maurizio Melis; Giulio Rosati; Gonçalo R Abecasis; Manuela Uda; Maria Giovanna Marrosu; David Schlessinger; Francesco Cucca
Journal:  Nat Genet       Date:  2010-05-09       Impact factor: 38.330

Review 2.  Genome-wide association studies for common diseases and complex traits.

Authors:  Joel N Hirschhorn; Mark J Daly
Journal:  Nat Rev Genet       Date:  2005-02       Impact factor: 53.242

3.  A multiple sclerosis-associated variant of CBLB links genetic risk with type I IFN function.

Authors:  Klarissa Hanja Stürner; Uwe Borgmeyer; Christian Schulze; Ole Pless; Roland Martin
Journal:  J Immunol       Date:  2014-09-26       Impact factor: 5.422

4.  Prevalence of multiple sclerosis in Saskatoon.

Authors:  W J Hader
Journal:  Can Med Assoc J       Date:  1982-08-15       Impact factor: 8.262

5.  A genome-wide association study in progressive multiple sclerosis.

Authors:  Filippo Martinelli-Boneschi; Federica Esposito; Paola Brambilla; Eva Lindström; Giovanni Lavorgna; Jim Stankovich; Mariaemma Rodegher; Ruggero Capra; Angelo Ghezzi; Gabriella Coniglio; Bruno Colombo; Melissa Sorosina; Vittorio Martinelli; David Booth; Annette Bang Oturai; Graeme Stewart; Hanne F Harbo; Trevor John Kilpatrick; Jan Hillert; Justin P Rubio; Hadi Abderrahim; Jerome Wojcik; Giancarlo Comi
Journal:  Mult Scler       Date:  2012-03-28       Impact factor: 6.312

6.  Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity.

Authors:  Timothy J Harris; Joseph F Grosso; Hung-Rong Yen; Hong Xin; Marcin Kortylewski; Emilia Albesiano; Edward L Hipkiss; Derese Getnet; Monica V Goldberg; Charles H Maris; Franck Housseau; Hua Yu; Drew M Pardoll; Charles G Drake
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

7.  Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis.

Authors:  Hanne F Harbo; Noriko Isobe; Pål Berg-Hansen; Steffan D Bos; Stacy J Caillier; Marte W Gustavsen; Inger-Lise Mero; Elisabeth Gulowsen Celius; Stephen L Hauser; Jorge R Oksenberg; Pierre-Antoine Gourraud
Journal:  Mult Scler       Date:  2013-10-07       Impact factor: 6.312

8.  Combining genetic mapping with genome-wide expression in experimental autoimmune encephalomyelitis highlights a gene network enriched for T cell functions and candidate genes regulating autoimmunity.

Authors:  Melanie Thessen Hedreul; Steffen Möller; Pernilla Stridh; Yask Gupta; Alan Gillett; Amennai Daniel Beyeen; Johan Öckinger; Sevasti Flytzani; Margarita Diez; Tomas Olsson; Maja Jagodic
Journal:  Hum Mol Genet       Date:  2013-07-29       Impact factor: 6.150

9.  TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.

Authors:  Adam P Gregory; Calliope A Dendrou; Kathrine E Attfield; Aiden Haghikia; Dionysia K Xifara; Falk Butter; Gereon Poschmann; Gurman Kaur; Lydia Lambert; Oliver A Leach; Simone Prömel; Divya Punwani; James H Felce; Simon J Davis; Ralf Gold; Finn C Nielsen; Richard M Siegel; Matthias Mann; John I Bell; Gil McVean; Lars Fugger
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

10.  Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects.

Authors:  Nikolaos A Patsopoulos; Lisa F Barcellos; Rogier Q Hintzen; Catherine Schaefer; Cornelia M van Duijn; Janelle A Noble; Towfique Raj; Pierre-Antoine Gourraud; Barbara E Stranger; Jorge Oksenberg; Tomas Olsson; Bruce V Taylor; Stephen Sawcer; David A Hafler; Mary Carrington; Philip L De Jager; Paul I W de Bakker
Journal:  PLoS Genet       Date:  2013-11-21       Impact factor: 5.917

View more
  10 in total

1.  A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactome.

Authors:  Alessandro Didonna; Noriko Isobe; Stacy J Caillier; Kathy H Li; Alma L Burlingame; Stephen L Hauser; Sergio E Baranzini; Nikolaos A Patsopoulos; Jorge R Oksenberg
Journal:  Hum Mol Genet       Date:  2015-10-03       Impact factor: 6.150

Review 2.  Caring for Women with Multiple Sclerosis Across the Lifespan.

Authors:  Kelsey Rankin; Riley Bove
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-23       Impact factor: 5.081

3.  An Integrated Bioinformatics Analysis of the Potential Regulatory Effects of miR-21 on T-cell Related Target Genes in Multiple Sclerosis.

Authors:  Mostafa Manian; Ehsan Sohrabi; Nahid Eskandari; Mohammad-Ali Assarehzadegan; Gordon A Ferns; Mitra Nourbakhsh; Mir Hadi Jazayeri; Reza Nedaeinia
Journal:  Avicenna J Med Biotechnol       Date:  2021 Jul-Sep

4.  Daphnetin Ameliorates Experimental Autoimmune Encephalomyelitis Through Regulating Heme Oxygenase-1.

Authors:  Dan Wang; Bo Zhu; Xiaoyi Liu; Qin Han; Weihong Ge; Wenping Zhang; Yin Lu; Qinan Wu; Liyun Shi
Journal:  Neurochem Res       Date:  2020-01-16       Impact factor: 3.996

Review 5.  Optical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.

Authors:  Praveena Manogaran; James V M Hanson; Elisabeth D Olbert; Christine Egger; Carla Wicki; Christina Gerth-Kahlert; Klara Landau; Sven Schippling
Journal:  Int J Mol Sci       Date:  2016-11-15       Impact factor: 5.923

Review 6.  Cytokine Signaling in Multiple Sclerosis and Its Therapeutic Applications.

Authors:  Pushpalatha Palle; Kelly L Monaghan; Sarah M Milne; Edwin C K Wan
Journal:  Med Sci (Basel)       Date:  2017-10-13

Review 7.  Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Int J Mol Sci       Date:  2018-04-16       Impact factor: 5.923

8.  The genetic effect of the ICAM1 (intercellular adhesion molecule 1) rs5498 polymorphism on the susceptibility towards multiple sclerosis.

Authors:  Chuan Jiang; Chunli Xie; Jianli Feng; Maolin Hao
Journal:  Biosci Rep       Date:  2018-12-11       Impact factor: 3.840

9.  Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry.

Authors:  Calvin Chi; Xiaorong Shao; Brooke Rhead; Edlin Gonzales; Jessica B Smith; Anny H Xiang; Jennifer Graves; Amy Waldman; Timothy Lotze; Teri Schreiner; Bianca Weinstock-Guttman; Gregory Aaen; Jan-Mendelt Tillema; Jayne Ness; Meghan Candee; Lauren Krupp; Mark Gorman; Leslie Benson; Tanuja Chitnis; Soe Mar; Anita Belman; Theron Charles Casper; John Rose; Manikum Moodley; Mary Rensel; Moses Rodriguez; Benjamin Greenberg; Llana Kahn; Jennifer Rubin; Catherine Schaefer; Emmanuelle Waubant; Annette Langer-Gould; Lisa F Barcellos
Journal:  PLoS Genet       Date:  2019-01-17       Impact factor: 5.917

10.  iPS-Derived Early Oligodendrocyte Progenitor Cells from SPMS Patients Reveal Deficient In Vitro Cell Migration Stimulation.

Authors:  Lidia Lopez-Caraballo; Jordi Martorell-Marugan; Pedro Carmona-Sáez; Elena Gonzalez-Munoz
Journal:  Cells       Date:  2020-07-29       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.